|
 |
|
|
|
Consultations
Dear BOPA member
In January 2010 BOPA launched its standards for verification of prescriptions for anticancer medicines. The committee is pleased to follow the standards document with a more detailed guidance document which aims to provide the 'detail behind the standards'. We'd be grateful for any comments on this document.
The consultation will last 3 weeks until Monday 8th March 2010
Thank you
Guidance to support BOPA Clinical Verification Standard v1.4
Consultation on BOPA Verifcation Supporting Guidance
Dear Colleague
Following Joanne Robinson's presentation at BOPA this year we are please to circulate the proposed BOPA Verification Standards for your comments. You have until 11th December to comment on the standards, In order to track comments and fairly consider conflicting views only comments received using the attached form will be considered.
We look forward to hearing your views.
The BOPA Committee
Email: steve.williamson@nhct.nhs.uk
BOPA Standards for Clinical Pharmacy Verification of SACT
Consultation on British Oncology Pharmacy Association
Section 5 - Patient Access and Flexible Pricing Schemes
Scope: How are NICE treating Access and Flexible Pricing Schemes in the appraisal process?
Deadline for comments: Friday 10th July 2009
Comments to:
Mark Evans
Email: mark.evans58@nhs.net
The National Cancer Network Pharmacist's are looking at the impact of Risk Share Schemes (or Market Access Schemes) on the local NHS. Nationally there is a growing number of these schemes being submitted to NICE with very little evidence of the impact on front line NHS staff, in particular in pharmacy services.
We would be grateful if you would contribute to the research which will ONLY take 10 minutes of your time. Please click on the link below to complete the survey.
Click Here to take survey
We are interested on your views even if you don't participate in the running the schemes. If you are not the person dealing with these scheme we would be grateful if you could pass on to the member of pharmacy staff in your Trust responsible for dealing with these schemes.
Deadline for completion is Monday 3rd August 2009
Any queries please direct to steve.williamson@nhct.nhs.uk
Thank you
Dave Thomson, Chair of BOPA, Network Pharmacist Yorkshire Cancer Network
&
Steve Williamson, Consultant Pharmacist, North of England Cancer Network
Background:
Risk Share Schemes are seen as a way of improving access to new medicines for NHS patients. It is essential, however, that the benefits and costs of initiatives such as offers to NHS of risk-sharing schemes by pharmaceutical manufacturers are assessed as carefully as those of the medicines themselves and to ensure that the schemes genuinely offer the NHS value-for-money.
Non Medical Prescribing Review Best Practice Guidelines
Deadline for comments: Wednesday 10th June 2009
Comments to:
Steve Williamson MRPharmS, MSc, FFCP
Consultant Pharmacist in Cancer Services
North of England Cancer Network (NECN), Team View, 5th Avenue Business Park, Team Valley, Gateshead NE11 0NB.
Work Mobile Number - 07768 995965
Email: steve.williamson@nhct.nhs.uk
Stakeholder Consultation on Draft Patient Safety Alert
Neuraxial Devices with Safer Connectors
A purchasing for safety initiative for neuraxial (spinal and epidural) medical devices with safer connectors to further minimise wrong route errors
Consultation Opens: Monday 20 April 2009
Consultation Closes Friday 19 June 2009
BOPA response: please send comments to David Thomson before 12th June 2009
To add to this page please contact a
website manager
|
|
|
|
